Molecule of the Month. PDGFR-alpha antagonist Gleevec reduces blood vessel leakage and increases the therapeutic window associated with tissue plasminogen activator stroke treatment.
作者信息
Lewis Jana A
机构信息
Vanderbilt University, Vanderbilt University Medical Center, Department of Pharmacology, Nashville, TN 37232-6600, USA.
出版信息
Curr Top Med Chem. 2008;8(15):1416-7. doi: 10.2174/156802608786141142.
PMID:19006853
Abstract
摘要
Zotero 插件